NACDS Foundation releases second wave of funding via Community PREP
ALEXANDRIA, Va. — The charitable arm of the National Association of Chain Drug Stores once again has released funding that will support 15 new residencies for recent pharmacy graduates.
The NACDS Foundation said that the funding, made through the Community Pharmacy Residency Expansion Project, will award an additional $750,000 in grants to support the residencies. The $1.5 million Community PREP program, established in December 2010, helps expand educational opportunities for recent pharmacy school graduates by pairing them with faculty members and preceptors to oversee residents’ learning experiences in patient-centered pharmacy practice sites, NACDS Foundation said.
“Community PREP provides essential funding to expand hands-on clinical research and education opportunities for community pharmacy’s future leaders,” NACDS Foundation president Kathleen Jaeger said. “Under the expert guidance of pharmacy veterans, residents will hone their abilities to deliver patient-centered health services and contribute to the evidence-base for community pharmacy-based clinical practice. These educational partnerships between pharmacy schools and community pharmacy practice sites provide exceptional opportunities to advance research and pharmacy education, and ultimately improve patient healthcare outcomes.”
Click here for an application.
Study: Link between diabetes drugs, pancreatic cancer risk unclear
NEW YORK — A new study published in the American Journal of Gastroenterology examined the possible link between pancreatic cancer and drugs designed to treat diabetes, and found the association to be unclear.
Researchers conducted a case-control study based on the British-based General Practice Research Database, which included drug prescriptions, diagnostics, hospitalizations and fatality information. The researchers also took into consideration such factors as body mass index, smoking, alcohol consumption and diabetes duration.
After examining 2,763 case patients that had a recorded diagnosis of pancreatic cancer, the researchers found that long-term use of metformin was associated with a decreased risk of pancreatic cancer only in women. Meanwhile, use of sulfonylureas and of insulin were associated with an increased risk of pancreatic cancer, they noted.
Click here for the full study.
Pfizer recalls 28 lots of branded, generic oral contraceptive
NEW YORK — A possible pill mix-up has prompted Pfizer to recall more than two dozen lots of a prescription contraceptive drug, the drug maker said.
Pfizer announced the voluntary nationwide recall of 14 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol) tablets and 14 additional lots of the drug’s generic version. Pfizer manufactured and packaged the drugs, while Akrimax Pharmaceuticals commercialized them, and they were sold under the Akrimax brand.
The company said an investigation found that some blister packs of the drugs may contain an inexact count of inert or active ingredient tablets and that the tablets may not be in the correct sequence. The packaging error could leave women without adequate contraception and put them at risk of unintended pregnancy, the company said.